These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1812002)

  • 41. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The TRH analogue CG3509 increases in vivo catechol/ascorbate oxidation in the N. accumbens but not in the striatum of the rat.
    Sharp T; Brazell MP; Bennett GW; Marsden CA
    Neuropharmacology; 1984 Jun; 23(6):617-23. PubMed ID: 6431310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Further investigation of allopurinol effects on MPTP-induced oxidative stress in the striatum and brain stem of the rat.
    Desole MS; Esposito G; Fresu L; Migheli R; Sircana S; Delogu R; Miele M; Miele E
    Pharmacol Biochem Behav; 1996 Jun; 54(2):377-83. PubMed ID: 8743598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum.
    Tanganelli S; von Euler G; Fuxe K; Agnati LF; Ungerstedt U
    Brain Res; 1989 Nov; 502(2):319-24. PubMed ID: 2819469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apomorphine lowers dopamine synthesis for up to 48 h: implications for drug sensitization.
    Rodriguez M; Castro R
    Neuroreport; 1991 Jul; 2(7):365-8. PubMed ID: 1680483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.
    Rivest R; Marsden CA
    Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Receptor characteristics and recovery of function following kainic acid lesions and fetal transplants of the striatum. I. Cholinergic systems.
    Deckel AW; Moran TH; Robinson RG
    Brain Res; 1988 Nov; 474(1):27-38. PubMed ID: 3214714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conditioning of behavioural effects produced by an intermediate dose of apomorphine: hypokinesia, ptosis and stereotypies.
    Nowak K; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):262-6. PubMed ID: 3683596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A dopaminergic mechanism mediates the d-amphetamine- and apomorphine-induced increase of ascorbic acid metabolism in the rat striatum.
    Miele M; Desole MS; Enrico P; Esposito G; De Natale G; Miele E
    Pharmacol Res; 1990; 22 Suppl 3():41-2. PubMed ID: 2097636
    [No Abstract]   [Full Text] [Related]  

  • 51. [Microdialysis study of tolcapone effect during blockage of neuronal dopamine reuptake caused by GBR-12909].
    Budygin EA; Gaĭnetdinov RR; Raevskiĭ KS; Li IH; Mannisto PT
    Eksp Klin Farmakol; 1997; 60(5):8-10. PubMed ID: 9483396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uric acid levels and dopamine transmission in rat striatum: diurnal changes and effects of drugs.
    O'Neill RD
    Brain Res; 1990 Jan; 507(2):267-72. PubMed ID: 2337766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopaminergic and cholinergic influences on motor behavior in chickens.
    Sanberg PR
    J Comp Psychol; 1983 Mar; 97(1):59-68. PubMed ID: 6872506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurochemical and behavioral studies on the mode of action of oxypertine.
    Moroji T; Okuyama T; Hagino Y; Sekiguchi R
    Arzneimittelforschung; 1986 May; 36(5):804-8. PubMed ID: 2873819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis.
    Akimoto K; Hamamura T; Otsuki S
    Brain Res; 1989 Jun; 490(2):339-44. PubMed ID: 2765867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
    Kaneno S; Watanabe A; Takahashi R
    Eur J Pharmacol; 1986 Apr; 123(2):287-94. PubMed ID: 3086109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum.
    Fornstedt B; Carlsson A
    J Neurochem; 1991 Feb; 56(2):407-14. PubMed ID: 1988547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chlorimipramine, electroconvulsive shock and combination thereof: differential effects of chronic treatment on apomorphine-induced behaviours and on striatal and mesocortical dopamine turnover.
    Spyraki C; Papadopoulou Z; Kourkoubas A; Varonos D
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):128-34. PubMed ID: 4040217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atrophy of the striatum and motor disturbance induced by colchicine.
    Kamata K; Okuyama S; Hashimoto S; Kumura MA; Aihara H; Kasuya Y
    Brain Res; 1987 Sep; 421(1-2):353-7. PubMed ID: 3690277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.